NCT00277602View on ClinicalTrials.gov

Riluzole in Huntington's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

537

Participants

Timeline

Start Date

November 30, 1999

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Huntington Disease
Interventions
DRUG

Riluzole

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00277602 - Riluzole in Huntington's Disease | Biotech Hunter | Biotech Hunter